Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
4.610
-0.290 (-5.92%)
At close: Nov 7, 2025, 4:00 PM EST
4.570
-0.040 (-0.87%)
After-hours: Nov 7, 2025, 4:21 PM EST
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $7.58 million as of November 7, 2025. Its market cap has decreased by -58.64% in one year.
Market Cap
7.58M
Enterprise Value
10.27M
1-Year Change
-58.64%
Ranking
Category
Stock Price
$4.61
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $7.58M, a decrease of -96.71%. That is a compound annual growth rate of -46.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 7.58M | -43.89% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | 147.37M | -35.97% |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |